Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  AMAG Pharmaceuticals, Inc.    AMAG

 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
03/20/2017 03/21/2017 03/22/2017 03/23/2017 03/24/2017 Date
22.65(c) 21.4(c) 21.75(c) 21.6(c) 22(c) Last
817 026 1 145 516 1 490 853 1 112 461 879 567 Volume
-3.62% -5.52% +1.64% -0.69% +1.85% Change
More quotes
Financials ($)
Sales 2017 644 M
EBIT 2017 291 M
Net income 2017 79,6 M
Debt 2017 381 M
Yield 2017 -
Sales 2018 535 M
EBIT 2018 225 M
Net income 2018 39,4 M
Debt 2018 316 M
Yield 2018 -
P/E ratio 2017 15,52
P/E ratio 2018 20,11
EV / Sales2017 1,76x
EV / Sales2018 2,00x
Capitalization 755 M
More Financials
Company
AMAG Pharmaceuticals, Inc. is a biopharmaceutical company that focuses on the development and commercialization of a therapeutic iron compound to treat iron deficiency anemia.It focuses on the development and commercialization of Feraheme injection for intravenous or IV, use to treat iron... 
Sector
Pharmaceuticals
Calendar
05/02Earnings Release
More about the company
Surperformance© ratings of AMAG Pharmaceuticals, Inc.
Trading Rating : Investor Rating :
More Ratings
Latest news on AMAG PHARMACEUTICALS, INC.
03/14 TWO BIOTECH CATALYSTS TO WATCH RIGHT : Bioline RX Ltd (NASDAQ:BLRX) and AMAG Pha..
03/06 AMAG PHARMACEUTICALS INC. : Change in Directors or Principal Officers, Regulatio..
03/06 AMAG Announces Management Changes and New Commercial Appointments
03/01 AMAG Pharmaceuticals to Present at Upcoming Investor Conferences
02/28 Antares Pharma Announces FDA Acceptance of New Drug Application for Quickshot..
02/27 AMAG and Palatin Announce Rekynda™ Data Presentations at the Internatio..
02/21 AMAG PHARMACEUTICALS INC. MANAGEMEN : (form 10-K)
02/16 PALATIN TECHNOLOGIES : Announces Closing of License Agreement with AMAG Pharmace..
02/15 AMAG PHARMACEUTICALS, INC. (NASDAQ : AMAG) Files An 8-K Entry into a Material De..
02/14 AMAG PHARMACEUTICALS : reports 4Q loss
More news
Sector news : Pharmaceuticals - NEC
03/24 NOVO NORDISK A/S : EMA panel backs Novo Nordisk's haemophilia B drug
03/24 YouTube's bid to grab TV dollars imperiled by advertiser revolt
03/23DJPRESS RELEASE : FDA Grants Approval for -3-
03/23DJPRESS RELEASE : FDA Grants Approval for -2-
03/23DJPRESS RELEASE : FDA Grants Approval for BAVENCIO(R) (avelumab), the First Immuno..
More sector news : Pharmaceuticals - NEC
Latest Tweets
03/20Would $AMAG buy $PTN outright with the latter’s Bremelanotide potential ? 
03/20AMAG Pharmaceuticals given $40.00 PT by Jefferies Group LLC. buy rating.  
03/18Two Biotech Catalysts To Watch Right Now: Bioline RX Ltd (BLRX) And AMAG Phar.. 
03/15Raymond James says this new study highlights the risks for $AMAG Pharmaceutic.. 
03/1511,200 Shares in AMAG Pharmaceuticals, Inc. $AMAG Acquired by Tudor Investmen.. 
More tweets
Qtime:19
News from SeekingAlpha
03/08 AMAG Pharmaceuticals (AMAG) Presents At The Raymond James 38th Annual Institu..
02/15 BIOTECH FORUM DAILY DIGEST : Bristol-Myers On The Block? Biotech Continues To Ro..
02/14 AMAG Pharmaceuticals' (AMAG) CEO Bill Heiden on Q4 2016 Results - Earnings Ca..
02/14 AMAG Pharmaceuticals, Inc. 2016 Q4 - Results - Earnings Call Slides
02/14 AMAG Pharmaceuticals EPS of -$0.31
Advertisement
Chart AMAG PHARMACEUTICALS, INC.
Duration : Period :
AMAG Pharmaceuticals, Inc. Technical Analysis Chart | AMAG | US00163U1060 | 4-Traders
Full-screen chart
Technical analysis trends AMAG PHARMACEUTIC...
Short TermMid-TermLong Term
TrendsBearishBearishNeutral
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 10
Average target price 28,7 $
Spread / Average Target 30%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
William K. Heiden Chief Executive Officer & Director
Frank E. Thomas President & Chief Operating Officer
Gino Santini Chairman
Edward H. Myles Chief Financial Officer, Treasurer & Senior VP
Julie Krop Chief Medical Officer & SVP-Regulatory Affairs
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
AMAG PHARMACEUTICALS, ..-36.78%755
JOHNSON & JOHNSON8.91%340 163
ROCHE HOLDING LTD.8.73%219 545
PFIZER INC.4.68%202 474
NOVARTIS AG-0.94%195 096
MERCK & CO., INC.7.32%173 465
More Results